Ignite Creation Date:
2025-12-24 @ 2:12 PM
Ignite Modification Date:
2025-12-26 @ 7:10 AM
Study NCT ID:
NCT05557695
Status:
RECRUITING
Last Update Posted:
2025-12-11
First Post:
2022-08-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Observational Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukaemia in the United Kingdom
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-10-17
Start Date Type:
ACTUAL
Primary Completion Date:
2027-04-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-04-01
Completion Date Type:
ESTIMATED
First Submit Date:
2022-08-24
First Submit QC Date:
None
Study First Post Date:
2022-09-28
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-05
Last Update Post Date:
2025-12-11
Last Update Post Date Type:
ESTIMATED